Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Times Interest Earned (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Times Interest Earned for 5 consecutive years, with -$48.34 as the latest value for Q2 2025.

  • For Q2 2025, Times Interest Earned rose 17.1% year-over-year to -$48.34; the TTM value through Dec 2025 reached -$91.07, down 60.12%, while the annual FY2024 figure was -$56.88, 20.88% up from the prior year.
  • Times Interest Earned hit -$48.34 in Q2 2025 for Kezar Life Sciences, up from -$50.8 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$48.34 in Q2 2025 and bottomed at -$88.7 in Q4 2021.
  • Average Times Interest Earned over 5 years is -$62.89, with a median of -$60.01 recorded in 2022.
  • Year-over-year, Times Interest Earned crashed 51.02% in 2023 and then surged 36.06% in 2024.
  • Kezar Life Sciences' Times Interest Earned stood at -$88.7 in 2021, then soared by 35.28% to -$57.4 in 2022, then plummeted by 51.02% to -$86.69 in 2023, then soared by 36.06% to -$55.43 in 2024, then increased by 12.79% to -$48.34 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$48.34, -$50.8, and -$55.43 for Q2 2025, Q1 2025, and Q4 2024 respectively.